Medicox

054180 · KOSDAQ · ₩054180 · 메디콕스

₩2,295 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩6.4B₩6.3B₩7B₩6.7B₩7.7B₩6.8B₩8.2B₩7.6B
Cost of sales₩6.2B₩5.8B₩7B₩5.8B₩6.9B₩6.2B₩7.6B₩7.1B
Gross profit₩249M₩553M−₩18M₩840M₩761M₩584M₩541M₩499M
Operating income−₩1.1B−₩1B−₩1.3B−₩923M−₩1.5B−₩2B−₩2.1B−₩2.2B
Net income₩498M−₩1.6B−₩10B₩1.8B−₩842M−₩2.9B−₩18B₩3.6B
Net income to shareholders₩498M−₩1.6B−₩10B₩1.8B−₩842M−₩2.9B−₩7.3B−₩3.8B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩69B₩69B₩68B₩72B₩77B₩84B₩81B₩79B
Current assets₩8.3B₩8.9B₩7.5B₩9.4B₩12B₩16B₩13B₩17B
Cash and equivalents₩40M₩36M₩377M₩585M₩589M₩4.6B₩1.2B₩436M
Total liabilities₩24B₩24B₩21B₩22B₩25B₩27B₩29B₩28B
Current liabilities₩19B₩19B₩16B₩16B₩19B₩22B₩24B₩24B
Borrowings₩8.5B₩8.5B₩8.5B₩8.7B₩11B₩16B₩18B₩19B
Total equity₩45B₩46B₩47B₩51B₩52B₩56B₩52B₩51B
Shareholders' equity₩45B₩46B₩47B₩51B₩52B₩56B₩52B₩51B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩836M−₩112M−₩79M−₩810M−₩286M−₩2.3B−₩530M−₩1.6B
Capital spending₩242M₩61M₩40M₩211M₩503M₩21M₩90M₩119M
Free cash flow₩594M−₩173M−₩118M−₩1B−₩789M−₩2.3B−₩620M−₩1.7B

Consolidated where available. Amounts in won.

Also known as: Medicox / 메디콕스 / 054180 / KRX:054180

Source: KRX statistical information